Suppression of these receptors-activated Akt-NF-κB signaling pathways by TFC and TNC could greatly contribute to the inhibition of the migration and growth of lung cancer LLC and A549 cells as well as the LLC and A549 tumor growth in tumor-bearing mice as we observed in the present study. The gene discussed is AKT1; the disease is lung cancer.